{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:45:50Z","timestamp":1791902750958,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The longitudinal impact of diabetes duration on the progression of insulin resistance (IR) in type 2 diabetes (T2DM) remains to be fully elucidated. It is also unclear whether this relationship is uniform across all patients or modified by specific metabolic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between diabetes duration and IR, and to identify critical effect modifiers that define high-risk trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled 3,309 patients with T2DM, categorized into non-IR (HOMA-IR &amp;lt; 2.31, n = 1,530) and IR (HOMA-IR \u2265 2.31, n\u00a0= 1,779) groups. Multivariable linear regression was used to assess the independent association between diabetes duration and HOMA-IR. Subgroup and interaction analyses were performed to identify effect modifiers. A two-piecewise linear regression model was employed to delineate threshold effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the overall cohort, diabetes duration was independently associated with higher HOMA-IR after full adjustment (\u03b2 = 0.04, 95% CI: 0.03-0.05,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). This association was significant only in the IR group (\u03b2 = 0.04, 95% CI: 0.02-0.06,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) and absent in the non-IR group. Subgroup analysis revealed that the TyG index was the only significant effect modifier (\u03b2\n                      <jats:sub>interaction<\/jats:sub>\n                      = 0.06, 95% CI: 0.02-0.09,\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      = 0.001). Crucially, a threshold effect was identified in the high-TyG group: HOMA-IR increased sharply by 0.08 per additional year of diabetes only after 4.0 years (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study defines a novel, actionable high-risk phenotype in T2DM, characterized by a combination of a TyG index \u2265 9.187 and diabetes duration exceeding 4.0 years, which is associated with a markedly accelerated increase in IR. Given that the TyG index is adjustable, this framework provides a clinically meaningful, personalized strategy for targeted early intervention, enabling precise prevention for those most susceptible to worsening insulin resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1762526","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:54:05Z","timestamp":1771397645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The triglyceride-glucose index modulates the association between diabetes duration and insulin resistance in type 2 diabetes: a large cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Ya","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Shenzhen Second People\u2019s Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen Clinical Research Center for Metabolic Diseases, Shenzhen Center for Diabetes Control and Prevention","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shenzhen Bao\u2019an Shiyan People\u2019s Hospital, Bao\u2019an Clinical Institute of Shantou University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shenzhen Second People\u2019s Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen Clinical Research Center for Metabolic Diseases, Shenzhen Center for Diabetes Control and Prevention","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shenzhen Second People\u2019s Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen Clinical Research Center for Metabolic Diseases, Shenzhen Center for Diabetes Control and Prevention","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shenzhen Second People\u2019s Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen Clinical Research Center for Metabolic Diseases, Shenzhen Center for Diabetes Control and Prevention","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122804","article-title":"Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic \u03b2-cell dysfunction for T2DM management","volume":"313","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: Review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12933-025-02956-6","article-title":"Evaluation of four insulin resistance surrogate indicators for predicting short-term mortality in critically ill patients with ischemic stroke: a nationwide retrospective cohort study","volume":"24","author":"Ouyang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1369600","article-title":"Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007\u20132016 analyses","volume":"15","author":"Zeng","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0358","article-title":"Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women\u2019s Health Initiative Observational Study","volume":"30","author":"Song","year":"2007","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mcna.2004.04.013","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"88","author":"DeFronzo","year":"2004","journal-title":"Med Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(98)00038-2","article-title":"Assessing the potential for alpha-glucosidase inhibitors in prediabetic states","author":"Holman","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0023","article-title":"Glucolipotoxicity: fuel excess and beta-cell dysfunction","volume":"29","author":"Poitout","year":"2008","journal-title":"Endocr Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108050","article-title":"Progression of insulin resistance: A link between risk factors and the incidence of diabetes","volume":"161","author":"Wu","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6:e70422","DOI":"10.1002\/mco2.70422","article-title":"Association of the triglyceride-glucose index with stroke and all-cause mortality in patients with coronary artery disease: A nationwide cohort study from 1999 to 2018","author":"Huang","year":"2020","journal-title":"MedComm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12933-025-02910-6","article-title":"Effect of changes in the triglyceride-glucose index on atherogenic lipid profiles in coronary artery disease patients receiving lipid-lowering therapy: a prospective cohort study","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12933-022-01638-x","article-title":"Association between triglyceride glucose index and atherosclerotic plaques and Burden: findings from a community-based study","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132663","article-title":"Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine","volume":"418","author":"Avagimyan","year":"2025","journal-title":"Int J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112103","article-title":"HOMA-IR and TyG index differ for their relationship with dietary, anthropometric, inflammatory factors and capacity to predict cardiovascular risk","volume":"222","author":"Sergi","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12933-025-02870-x","article-title":"Association between triglyceride-glucose-body mass index and adverse prognosis in elderly patients with severe heart failure and type 2 diabetes: a retrospective study based on the MIMIC-IV database","volume":"24","author":"Cheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102052","article-title":"Diabetic cardiomyopathy: 2023 update by the international multidisciplinary board of experts","volume":"49","author":"Avagimyan","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3760\/j:issn:0253-3758.2003.12.007","article-title":"Shanghai adult metabolic syndrome prevalence survey","volume":"31","author":"Chen","year":"2003","journal-title":"Chin J Cardiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028","article-title":"From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.041","article-title":"The origins and drivers of insulin resistance","volume":"152","author":"Johnson","year":"2013","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.125.322196","article-title":"Influence of weight loss and weight regain on adipose tissue inflammation","volume":"45","author":"Caceres","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106007","article-title":"Impaired mitochondrial ketone body oxidation in insulin resistant states","volume":"122","author":"Zweck","year":"2025","journal-title":"EBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12933-025-02963-7","article-title":"Associations between triglyceride-glucose-related indices and all-cause and cardiovascular mortality among individuals with atrial fibrillation and metabolic syndrome: a cohort study of the UK biobank","volume":"24","author":"Ding","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-025-02687-8","article-title":"Association of triglyceride-glucose index trajectories with the risk of worsening heart failure in elderly patients with chronic heart failure and type 2 diabetes: a competing risk analysis","volume":"24","author":"Lai","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1674477","article-title":"Mitochondrial bioenergetics dysfunction in T2DM: linking oxidative stress to insulin resistance","volume":"16","author":"Feng","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e00349","DOI":"10.1097\/XCE.0000000000000349","article-title":"Insulin resistance spawns hypertriglyceridemia-induced acute pancreatitis and diabetic ketoacidosis: an evolving metabolic cascade","volume":"14","author":"Wu","year":"2025","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26072101","article-title":"\u03b2-sitosterol circumvents obesity induced inflammation and insulin resistance by down-regulating IKK\u03b2\/NF-\u03baB and JNK signaling pathway in adipocytes of type 2 diabetic rats","volume":"26","author":"Jayaraman","year":"2021","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e70337","DOI":"10.1002\/mnfr.70337","article-title":"Saponins from chenopodium quinoa willd. Improve insulin resistance and restore pancreatic \u03b2-cell function via anti-endoplasmic reticulum stress mechanisms","volume":"70","author":"Gao","year":"2026","journal-title":"Mol Nutr Food Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12933-025-02783-9","article-title":"The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study","volume":"24","author":"Zhao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"19571","DOI":"10.1038\/s41598-025-03948-y","article-title":"The triglyceride-glucose index positively associates with the prevalence and severity of coronary heart disease in patients among hypertension","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"19054","DOI":"10.1038\/s41598-024-70008-2","article-title":"Higher triglyceride glucose index is associated with increased risk of stroke among middle-aged and elderly Chinese: a national longitudinal study","volume":"14","author":"Xu","year":"2024","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0470","article-title":"SGLT2 inhibitor dapagliflozin increases skeletal muscle and brain fatty acid uptake in individuals with type 2 diabetes: A randomized double-blind placebo-controlled positron emission tomography study","volume":"47","author":"Latva-Rasku","year":"2024","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.2013077","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1762526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:48:50Z","timestamp":1791899330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1762526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":45,"alternative-id":["10.3389\/fendo.2026.1762526"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1762526","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1762526"}}